Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Trigeminal nerve sensory fibers are peripheral nerve fibers responsible for transmitting somatosensory information—including pain, temperature, light touch, and proprioception—from the face, oral cavity, and cranial structures to the brain via the trigeminal nerve (cranial nerve V) and its branches[1][4][7]. These fibers arise from sensory neurons in the trigeminal ganglion; they are highly heterogeneous, comprising several subtypes such as unmyelinated C-fibers, small myelinated Aδ-fibers, and large myelinated Aβ-fibers, each specialized for different sensory modalities[2][8]. Their central projections terminate in the trigeminal sensory nucleus complex in the brainstem, specifically the spinal trigeminal nucleus (for pain and temperature), principal sensory nucleus (for touch), and mesencephalic nucleus (for proprioception)[1][4][7]. Neuropeptides such as CGRP and substance P are released by subsets of these fibers, playing essential roles in pain transmission and modulation [3][5][8]. Dysfunction or hyperexcitability of these fibers is implicated in clinical conditions like trigeminal neuralgia, migraine, and other facial pain syndromes; therapies may target voltage-gated sodium channels or neuropeptide receptors for pain relief[3][6][8]. However, "trigeminal nerve sensory fiber" is not a single molecular therapeutic target but rather a collective term for a class of nerve fibers; thus, the term is not strictly correct when referring to a canonical, druggable protein or receptor target[3][6][8].
Inhibition of voltage-gated sodium channels (by carbamazepine, oxcarbazepine, lidocaine)[3][6] Blockade of CGRP signaling (by gepants and anti-CGRP monoclonal antibodies)[3] Stabilization of hyperexcitable neuronal membranes (sodium channel blockers)[6]
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Trigeminal nerve sensory fiber.